NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biohaven Ltd.

We recently published a list of 12 Stocks with Heavy Insider Buying in 2025. In this article, we are going to take a look at ...

NEW YORK, NY / ACCESS Newswire / March 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

Several brokerages have commented on BHVN. JPMorgan Chase & Co. lowered their target price on shares of Biohaven from $72.00 to $68.00 and set an “overweight” rating for the company in a ...

On Monday, Piper Sandler reiterated its Overweight rating and $76.00 price target on Biohaven Pharmaceutical (TADAWUL:2070) ...

Biohaven (NYSE:BHVN – Free Report) had its price objective lowered by Morgan Stanley from $69.00 to $63.00 in a research note released on Friday,Benzinga reports. The brokerage currently has an ...

Explore Biohaven stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BHVN. Strong Immunoglobulin Reduction Data Positions Biohaven's BHV-1300 As Potential ...

In trading on Tuesday, shares of Biohaven Ltd (Symbol: BHVN) crossed above their 200 day moving average of $40.76, changing hands as high as $42.68 per share. Biohaven Ltd shares are currently ...